Dr. Reddy's Labs
PharmaSmall capNSE: DRREDDY · ₹1.07 L Cr market cap
₹1,288
-2.02%Price chart
Simulated series for demonstration
About the company
Dr. Reddy's Labs operates in the pharma sector and is classified as a small-cap company with a market capitalisation of ₹1.07 L Cr. Reported return on equity is 16.3% with revenue growth of 24.7% and a debt-to-equity ratio of 1.88. Company descriptions and figures shown here are sample data for demonstration.
Volume
225 L
Beta
0.85
Dividend yield
0.70%
6M momentum
-5.4%
Analyst context
Aggregated sample view
- Coverage24 analysts
- Consensus stanceMixed
- Range of estimates1,095–1,546
Analyst estimates describe other people's expectations. They are not a forecast by ArthVue and are not a recommendation.
Market investments are subject to market risks. Past performance is not indicative of future results. Nothing here is investment advice.